Bio Products Laboratory announced that the FDA has approved Gammaplex 10% (immune globulin intravenous [human], 10% liquid) for the treatment...
The National Institute for Health and Clinical Excellence (NICE) has rejected the use of Esbriet(pirfenidone), from InterMune, on the National...
Glaucoma treatment options and patient management
Emerging evidence is revealing that severe coronavirus disease 2019 (COVID-19) is associated with coagulation abnormalities and an increased risk of venous thromboembolism. Could patients with severe cases of COVID-19 benefit from anticoagulant therapy?
Hospira has won a UK court judgement to invalidate two Roche patents for Herceptin opening the way for a generic...